Aromatherapy and Pain

NCT ID: NCT05910892

Last Updated: 2025-06-22

Basic Information

• Recruitment Status: WITHDRAWN
• Clinical Phase: NA
• Study Classification: INTERVENTIONAL
• Study Start Date: 2025-01-31
• Study Completion Date: 2025-07-31

Brief Summary

Effect of aromatherapy on pain and discomfort in patients who are receiving intramuscular stimulation therapy or trigger point injections for chronic pain.

Detailed Description

The study will explore the effect of aromatherapy on pain and discomfort in patients who are receiving intramuscular stimulation therapy or trigger point injections for chronic pain. This will be a blinded study where patients will act as their own control over two treatment visits. On one visit patient will be exposed to either the aromatherapy or a placebo. On their second visit patients will be exposed to the other compound. The study will collect demographic data, pain intensity and affect, and catastrophizing information.

Conditions

Chronic Pain

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: CROSSOVER
• Primary Study Purpose: PREVENTION
• Blinding Strategy: TRIPLE

Study Groups

Aromatherapy before treatment

Subject receives aromatherapy before IMS treatment or trigger point injection

Group Type: ACTIVE_COMPARATOR

Aromatherapy packet

Intervention Type: DRUG

5 deep breaths from packet prior to treatment

Placebo before treatment

Subject receives placebo before IMS treatment or trigger point injection

Group Type: PLACEBO_COMPARATOR

Placebo packet

Intervention Type: DRUG

5 deep breaths from packet prior to treatment

Interventions

Aromatherapy packet

5 deep breaths from packet prior to treatment

Intervention Type: DRUG

Placebo packet

5 deep breaths from packet prior to treatment

Intervention Type: DRUG

Other Intervention Names

Aromatherapy; Placebo

Eligibility Criteria

Inclusion Criteria

• Have received at least one (1) prior IMS or trigger point injection treatment with researcher
• 18 years of age or older
• English language speaker
• has completed Pain Tracker (clinic standard of care) questionnaire prior to study visit
• any analgesic medication taken must be consistent for both sessions

Exclusion Criteria

• Non-English language speaker
• Age <18
• Allergy to essential oils
• Asthmatic
• Patient unable to self-administer aromatherapy

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University of Washington

OTHER

Sponsor Role: lead

Responsible Party

Heather Tick

Clinical Professor: School of Medicine

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Heather Tick, MD

Role: PRINCIPAL_INVESTIGATOR

University of Washington

Other Identifiers

STUDY00007869

Identifier Type: -

Identifier Source: org_study_id